影响严重喘2型向治疗反应不佳的因素:一项回顾性队列研究
Mona Al-Ahmad1,2, Asmaa Ali3,4,5, Ahmed Maher4
1Microbiology Department, College of Medicine, Kuwait University, P.O. Box 24923, Kuwait City, 13110, Kuwait. mona.alahmad@ku.edu.kw.
BMC pulmonary medicine
|December 5, 2023
概括
鉴定严重喘生物制剂反应不良的因素是关键. 儿童发作的喘,支气管切除和口服皮质类固醇使用预测对奥马利祖马布的反应不佳,而女性性别,儿童发作的喘和更高的BMI预测对本拉利祖马布的反应不佳.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘管理已经推进了表型识别和更新的指导方针.
- 2型向疗法如本拉利祖马布和奥马利祖马布可以改善喘控制.
- 了解对这些生物制剂反应不佳的因素至关重要.
研究的目的:
- 评估与严重喘患者对奥马利祖马布和本拉利祖马布反应不佳相关的因素.
- 为了确定预测治疗失败的特定患者特征.
主要方法:
- 对162名开始生物治疗的严重喘患者进行了回顾性单中心队列研究.
- 从医疗记录中分析数据,以确定治疗反应不佳的预测因素.
- 低响应者被定义为患者,尽管接受了最大限度的治疗,但仍然无法控制.
主要成果:
- 儿童发作的喘,支气管切除,症状控制不良,严重的呼吸道阻塞和维持性口服皮质类固醇 (mOCS) 使用与这两种药物的反应不佳有关.
- 与缺血性心脏病 (IHD),支气管切除和mOCS使用相关的奥马利祖马布反应不佳.
- 与女性性别,儿童发作的喘和更高的体重指数 (BMI) 相关的本拉利祖马布反应不佳.
结论:
- 对奥马利祖马布的反应不佳与IHD,支气管切除症和之前使用mOCS有关.
- 对本拉利祖马布的反应不佳与女性性别,儿童发作的喘和更高的BMI有关.
- 这些发现有助于个性化严重喘的生物治疗选择.
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
272
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
272
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
320
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
320
01:20Asthma: Pathogenesis and Management
411
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
411
01:17Drugs Used in Lower Respiratory Disorders: Overview
451
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
451
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K